Cite
HARVARD Citation
You, B. et al. (2016). Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group–174 Phase III Trial. International journal of gynecological cancer. 26 (1), p. . [Online].